Jim Cramer Says “Look, in the End, There’s Eli Lilly and There’s Everybody Else”

Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently shared thoughts on. Cramer mentioned the stock ...

3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 Drugs

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

This next-gen weight-loss drug offers a new hope — and a bonus Ozempic and Wegovy don’t have

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

Here’s What Weighed on Eli Lilly and Company’s (LLY) Performance

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...

Eli Lilly, Walmart partner to bring Zepbound to customers with direct-to-consumer pricing

Eli Lilly and Company and Walmart have announced a partnership to offer Zepbound single-dose vials at Walmart pharmacies. The ...
PharmiWeb

Eli Lilly and NVIDIA Unveil Pharma’s Next-Gen AI Supercomputer

Eli Lilly partners with NVIDIA to build the world’s most powerful AI supercomputer in pharma, accelerating drug discovery and ...
Indianapolis Business Journal

Eli Lilly to build $3B manufacturing site in Netherlands

The facility is expected to produce oral medications, including Lilly's highly anticipated GLP-1 pill for weight loss, orforglipron.

Lilly, Walmart launch first retail pick-up option for weight-loss drug

Eli Lilly said on Wednesday it is partnering with Walmart to expand access to Lilly's weight-loss drug Zepbound, which will ...
Fierce Biotech

Eli Lilly links amylin agonist to 20% weight loss, sparking charge into phase 3

Eli Lilly has linked its amylin agonist eloralintide to up to 20.1% weight loss at Week 48, encouraging the drugmaker to ...